27 results
TAVI session from EuroPCR 2026: Abbott
25 Jun 2026
Watch this recording from EuroPCR 2026 on TAVI.
Mitral sessions from EuroPCR 2026: Abbott
25 Jun 2026
Watch these recordings from EuroPCR 2026 et PCR London Valves 2025 and on Mitral.
Tricuspid Valve session from EuroPCR 2026: Abbott
25 Jun 2026
Watch these recordings from EuroPCR 2026 and PCR London Valves 2025 on tricuspid valve.
Shockwave C2 Aero: Early experience in complex calcified coronary lesions
27 May 2026
Dr. Yousif Ahmad and Dr. Brett Wanamaker discuss how improved deliverability may influence calcium modification strategies in complex PCI.
In this case-based discussion, Dr. Yousif Ahmad and Dr. Brett Wanamaker share their early experience with Shockwave C2 Aero in complex calcified coronary anatomy. Through challenging real-world cases,...
The importance of PPM in younger patients in TAVI valve choice
08 Dec 2025
Kristoffer Russell discusses prosthesis–patient mismatch (PPM), which can increase mortality, heart failure hospitalisations, and reduce functional recovery, especially in younger patients. While less common after TAVI than surgical valve replacement, studies show up to 30% of younger, low-risk TAVI patients still experience moderate or severe PPM,...
Targeting inflammation in AMI: a debate - Video replay
16 Aug 2024
Watch this session to explore inflammation's role in AMI, including IL-6's significance and strategies for targeting inflammation.
CoreValve™ and Evolut™ TAVI systems
13 May 2022
Sponsored by Medtronic
Bifurcation Lesions Sessions
17 Feb 2022
Watch the recordings of these sessions on PCR in patients with complex lesions ACS and HBR and complex Bifurcation PCI: What to avoid?
Medtronic TAVI Sessions from PCR London Valves 2021
10 Dec 2021
Watch these recordings from PCR London Valves on TAVI.
Real-world outcomes with the PASCAL Platform in TR
03 Dec 2021
The PASCAL platform, comprising the PASCAL and PASCAL Ace implants, received its CE mark for TR in May 2020 and has been shown to be an effective and safe treatment option for patients with TR.3,4,6 Professor Jörg Hausleiter and Dr Mirjam Wild now describe their single-centre experience...
